Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Theophylline for Traumatic Anosmia
NCT07171021Phase 4Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of theophylline in traumatic anosmia (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Traditional Chinese Version of the University of Pennsylvania Identification Test at 7 months and Phenyl Ethyl Alcohol Odor Detection Threshold at 7 months. Started Dec 2020; status: completed.
02
Drugs
theophylline
03
Conditions
traumatic anosmia
Beyond the preview
Go deeper on NCT07171021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07171021.